Status:

RECRUITING

Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae

Lead Sponsor:

Ain Shams University

Conditions:

Lignocaine

Bupivacaine

Eligibility:

FEMALE

18-40 years

Phase:

NA

Brief Summary

In this study, we will compare the effect and safety of lignocaine versus bupivacaine infiltration for postpartum perineal pain after vaginal delivery with episiotomy in primigravidae.

Detailed Description

Episiotomy is the most common procedure used for dilatation of the vaginal opening for giving birth. Although episiotomy is associated with benefits for the mother, it may lead to short term and long-...

Eligibility Criteria

Inclusion

  • Primigravidae with the full term undergoing vaginal delivery with episiotomy.
  • Pregnancies and singleton vertex cephalic fetuses.
  • In the active phase of the first stage of labor.

Exclusion

  • Patients with history of drug allergies to study drugs as this will increase the risk of complications.
  • Patients undergoing vaginal delivery under epidural or spinal anesthesia as they will affect post-operative pain and interfere with assessment of efficacy of local infiltration of the study drugs.
  • Evidence of local infection at site of injection as this will interfere with the action of the study drug and will increase the risk of complications.
  • Inability to cooperate as this will affect our assessment.
  • Patient's refusal.
  • Any intraoperative complications that will affect our outcome criteria (bleeding, organ injury) as they will affect patient's vital data and affect our assessment.
  • Neurological comorbidities (chronic pain disorder, chronic systemic disease, neurological disorder, neuropathic pain) as they will need more analgesia.
  • Drug abuse as they will be tolerant to the used analgesics.

Key Trial Info

Start Date :

March 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06568289

Start Date

March 1 2024

End Date

September 1 2024

Last Update

August 23 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ain Shams University

Cairo, Egypt